Since its inception, Myriad has always taken "meeting customer needs" as the driving force for growth, and has gradually established an R&D management platform oriented to customer needs and centered on project management, so as to stay close to the market to fully understand user needs and quickly respond to them, and to provide high performance and price-performance products and services to global healthcare organizations by integrating innovative technologies and R&D and production cost advantages. With the integration of innovative technologies and cost advantages in R&D and production, we can provide high performance-price ratio products and services for global medical organizations and create greater value for our customers.
Mediatech currently has six R&D centers located in Shenzhen, Beijing, Nanjing, Seattle, New Jersey and Stockholm. Nearly 30% of Myriad's employees work in the R&D system on a wide range of products with clinical applications.
Mediatech has invested approximately 10% of its annual turnover in supporting product innovation and R&D, and has established an R&D management platform that is on par with the best in the world. Myriad has an R&D management process that complies with CE, FDA standards and ISO system, and an expert committee controls and manages the development process. All products are designed in accordance with relevant international standards during the development process, and comprehensive special tests (including EMC, safety, environmental, etc.) are conducted for verification, so that product safety and reliability are fully guaranteed.
In December 2002, the "National Engineering Research Center for Medical Diagnostic Instruments" of the Ministry of Science and Technology (MOST) was successfully established in Myriad. After three years of operation, the center was formally established in 2006 by the Ministry of Science and Technology of the People's Republic of China. It marks a new mechanism for Myriad to lead and enhance the technology research and development process of the domestic medical equipment industry. Actively participating in the construction of industry regulations and standards Mastering core technologies and launching high-tech products
Providing mature and supporting technologies for industrialized production Providing key technologies and components to the same industry
Becoming a training base for talents in the industry 1992 China's first oxygen saturation monitor
1993 China's first multi-parameter monitor
1994 China's first centralized monitor
The first centralized monitor
In 1994, China's first centralized monitor was developed. >1994 China's first central monitoring system
1998 China's first portable multi-parameter monitor
2003 China's first wireless central monitoring system
2006 China's first modular information monitor
2006 China's first anesthesia machine integrating multi-parameter monitoring and information technology
2009 China's first biphasic wave defibrillator with fully independent intellectual property rights 1998 China's first quasi-automatic blood cell analyzer2001 China's first automatic blood cell analyzer
2003 China's first automatic biochemistry analyzer
2005 China's first closed puncture sample feeder China's first automatic blood cell analyzer
2006 China's first automatic five-category blood cell analyzer
2010 China's first high-speed automatic biochemical line 1993 China's first transcranial Doppler cerebral blood flow diagnostic instrument
2001 China's first all-digital, high-grade, black and white ultrasound diagnostic instrument
2004 China's first all-digital portable ultrasound diagnostic instrument
2006 China's first desktop color Doppler ultrasound system with fully independent intellectual property rights
2008 China's first portable color Doppler ultrasound system with fully independent intellectual property rights
2009 China's first mid-range and high-end desktop color Doppler ultrasound system with fully independent intellectual property rights
Transcranial Doppler Cerebral Blood Flow Diagnostic System Doppler Ultrasound System